Murphy Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $5.17M | Buy |
56,733
+72
| +0.1% | +$6.38K | 0.72% | 41 |
|
|
2022
Q1 | $4.65M | Sell |
56,661
-333
| -0.6% | -$26.3K | 0.54% | 47 |
|
|
2021
Q4 | $4.37M | Sell |
56,994
-569
| -1% | -$45.3K | 0.47% | 56 |
|
|
2021
Q3 | $4.32M | Sell |
57,563
-7,102
| -11% | -$540K | 0.51% | 51 |
|
|
2021
Q2 | $5.03M | Sell |
64,665
-3,019
| -4% | -$225K | 0.58% | 47 |
|
|
2021
Q1 | $4.98M | Sell |
67,684
-2,681
| -4% | -$198K | 0.63% | 42 |
|
|
2020
Q4 | $5.49M | Sell |
70,365
-1,076
| -2% | -$82.3K | 0.73% | 37 |
|
|
2020
Q3 | $5.65M | Sell |
71,441
-233
| -0.3% | -$18.3K | 0.82% | 35 |
|
|
2020
Q2 | $5.29M | Buy |
71,674
+4,323
| +6% | +$325K | 0.84% | 33 |
|
|
2020
Q1 | $4.94M | Sell |
67,351
-10
| -0% | -$786 | 0.94% | 32 |
|
|
2019
Q4 | $5.84M | Sell |
67,361
-905
| -1% | -$74.3K | 0.83% | 37 |
|
|
2019
Q3 | $5.48M | Buy |
68,266
+1,039
| +2% | +$83.3K | 0.82% | 37 |
|
|
2019
Q2 | $5.38M | Buy |
67,227
+10,555
| +19% | +$808K | 0.8% | 39 |
|
|
2019
Q1 | $4.5M | Buy |
56,672
+3,031
| +6% | +$227K | 0.69% | 44 |
|
|
2018
Q4 | $3.91M | Buy |
53,641
+7,152
| +15% | +$505K | 0.66% | 45 |
|
|
2018
Q3 | $3.15M | Sell |
46,489
-641
| -1% | -$40.8K | 0.44% | 59 |
|
|
2018
Q2 | $2.73M | Buy |
47,130
+446
| +1% | +$25.2K | 0.39% | 65 |
|
|
2018
Q1 | $2.43M | Sell |
46,684
-761
| -2% | -$41.1K | 0.34% | 75 |
|
|
2017
Q4 | $2.55M | Sell |
47,445
-2,180
| -4% | -$121K | 0.35% | 78 |
|
|
2017
Q3 | $3.03M | Buy |
49,625
+345
| +0.7% | +$20.9K | 0.43% | 67 |
|
|
2017
Q2 | $3.01M | Sell |
49,280
-537
| -1% | -$32.7K | 0.44% | 66 |
|
|
2017
Q1 | $3.02M | Buy |
49,817
+216
| +0.4% | +$13.1K | 0.45% | 66 |
|
|
2016
Q4 | $2.79M | Buy |
49,601
+416
| +0.8% | +$24.3K | 0.44% | 67 |
|
|
2016
Q3 | $2.93M | Sell |
49,185
-240
| -0.5% | -$14K | 0.45% | 63 |
|
|
2016
Q2 | $2.72M | Buy |
49,425
+1,498
| +3% | +$79.7K | 0.42% | 63 |
|
|
2016
Q1 | $2.42M | Sell |
47,927
-23,497
| -33% | -$1.15M | 0.38% | 67 |
|
|
2015
Q4 | $3.6M | Buy |
71,424
+21,229
| +42% | +$1.07M | 0.55% | 52 |
|
|
2015
Q3 | $2.37M | Sell |
50,195
-2,419
| -5% | -$129K | 0.39% | 70 |
|
|
2015
Q2 | $2.86M | Sell |
52,614
-906
| -2% | -$50.8K | 0.43% | 65 |
|
|
2015
Q1 | $2.94M | Sell |
53,520
-154
| -0.3% | -$8.72K | 0.43% | 66 |
|
|
2014
Q4 | $2.91M | Buy |
53,674
+169
| +0.3% | +$9.42K | 0.44% | 67 |
|
|
2014
Q3 | $3.03M | Sell |
53,505
-1,944
| -4% | -$109K | 0.47% | 60 |
|
|
2014
Q2 | $3.06M | Buy |
55,449
+1,039
| +2% | +$56.7K | 0.48% | 59 |
|
|
2014
Q1 | $2.95M | Sell |
54,410
-82
| -0.2% | -$4.25K | 0.5% | 58 |
|
|
2013
Q4 | $2.6M | Buy |
54,492
+2,389
| +5% | +$109K | 0.45% | 65 |
|
|
2013
Q3 | $2.37M | Buy |
52,103
+3,080
| +6% | +$141K | 0.45% | 67 |
|
|
2013
Q2 | $2.17M | Buy |
+49,023
| New | +$2.19M | 0.44% | 66 |
|
Other funds holding MRK
Murphy Capital Management's MRK Position: Q2 2022 in Review
Murphy Capital Management increased its Merck (MRK) stake by 0.13% in Q2 2022, buying an estimated $6.38K and bringing the position to 56,733 shares worth $5.17M. The position accounts for 0.72% of the portfolio, ranked #41.
Murphy Capital Management first reported a position in MRK in Q2 2013 and has held it in 37 quarters since. The position peaked at $5.84M in Q4 2019. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.
- Murphy Capital Management held 56,733 shares of Merck worth $5.17M as of Q2 2022.
- Murphy Capital Management bought 72 Merck shares in Q2 2022, an estimated $6.38K.
- Merck made up 0.72% of Murphy Capital Management's portfolio in Q2 2022, its #41 holding.
- Murphy Capital Management first reported a position in Merck in Q2 2013 and has held it in 37 quarters since.
- Murphy Capital Management's Merck position peaked at $5.84M in Q4 2019.
- 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.
Based on Murphy Capital Management's 13F filing for Q2 2022, filed 13 Jul 2022.